Head and Neck Cancer Metastatic
6 clinical trials · Condition
◉ Watch Head and Neck Cancer Metastatic
| Record | Firm | Date |
|---|---|---|
| Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer (NCT03993353) | University of California, San Diego | 2020-04-07 |
| Preoperative Immune Checkpoint Inhibitor for Patients With Primary Untreated or Recurrent/Metastatic SCCHN (NCT03878979) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-07-08 |
| A Study of ADXS-NEO Expressing Personalized Tumor Antigens (NCT03265080) | Advaxis, Inc. | 2018-03-28 |
| Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck (NCT02474368) | Dana-Farber Cancer Institute | 2015-11-01 |
Track Head and Neck Cancer Metastatic automatically
Every clearance here is in the API, with alerts when new ones post.